This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Shionogi Company Limited. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Innovations of Setsuya Shibahara: A Patent Portfolio
Introduction
Setsuya Shibahara, an accomplished inventor based in Amagasaki, Japan, has made notable contributions to the field of chemistry. With a focus on developing innovative compounds, he holds two patents that reflect his expertise and commitment to advancing science.
Latest Patents
Shibahara's latest inventions revolve around the "Process for preparing substituted polycyclic pyridone derivative and crystal thereof." This patent details an innovative process aimed at preparing a specific compound, identified by the formula (II). The significance of this work lies in its potential applications within various chemical industries, showcasing Shibahara's ingenuity and technical proficiency.
Career Highlights
Shibahara is currently associated with Shionogi & Company Limited, a reputable pharmaceutical company known for its research and development in innovative healthcare solutions. His work at Shionogi underscores his dedication to creating impactful inventions that align with the company's vision for advancing medical science.
Collaborations
In his professional journey, Setsuya Shibahara has collaborated with various experts, including his coworker Kosuke Anan. Such collaborations reflect the importance of teamwork in the research and development process, fostering an environment where innovative ideas can flourish.
Conclusion
In summary, Setsuya Shibahara is a distinguished inventor whose patents contribute to the field of chemistry, particularly concerning polycyclic derivatives. With his association with Shionogi & Company Limited and his collaborative efforts, he continues to pave the way for future innovations that can enhance medical and chemical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
